Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myelomaFaith E. Davies, Kenneth C. Anderson, Noopur Raje et al.|Blood|2001Cited by 905
Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myelomaTeru Hideshima, Kenneth C. Anderson|Proceedings of the National Academy of Sciences|2005Cited by 596
Advances in biology of multiple myeloma: clinical applicationsTeru Hideshima, Kenneth C. Anderson|Blood|2004Cited by 583
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341Teru Hideshima, Kenneth C. Anderson|Blood|2003Cited by 569
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cellsTeru Hideshima, Kenneth C. Anderson|Blood|2006Cited by 421